| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.253.089.776 $ | +67.260.502 $ | +11,3 % | 11 | 1.338.306.750 $ | +497.334.539 $ | +68,9 % | 9 | 658.670.993 $ | +430.618.391 $ | +345,3 % | 5 | ||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Schwach | 285.299.245 $ | +5.296.245 $ | +1,9 % | 1 | 280.003.000 $ | +227.003.000 $ | +428,3 % | 1 | ||||
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 160.013.416 $ | -63.826.581 $ | -28,5 % | 1 | 223.839.997 $ | +16.805.878 $ | +8,1 % | 1 | 207.034.119 $ | +176.140.539 $ | +570,2 % | 1 |
| Abivax S.A. | ABVX | → 0 | Sehr schwach | 84.626.000 $ | -97.428.250 $ | -53,5 % | 1 | 182.054.250 $ | +16.499.250 $ | +10,0 % | 1 | 165.555.000 $ | +149.260.500 $ | +916,0 % | 1 |
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 153.577.500 $ | +153.577.500 $ | 1 | ||||||||||
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 106.535.850 $ | -44.465.700 $ | -29,4 % | 1 | 151.001.550 $ | +32.453.550 $ | +27,4 % | 1 | 118.548.000 $ | +40.209.750 $ | +51,3 % | 1 |
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Schwach | 102.690.000 $ | +21.172.725 $ | +26,0 % | 1 | 81.517.275 $ | +16.475.075 $ | +25,3 % | 1 | ||||
| Rapport Therapeutics, Inc. | RAPP | → 0 | Neutral | 92.540.832 $ | +685.845 $ | +0,7 % | 1 | 91.854.987 $ | -2.962.887 $ | -3,1 % | 1 | 94.817.874 $ | +61.379.602 $ | +183,6 % | 1 |
| Erasca, Inc. | ERAS | → 0 | Schwach | 93.844.000 $ | +93.844.000 $ | 1 | |||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Schwach | 91.788.000 $ | +19.072.000 $ | +26,2 % | 1 | 72.716.000 $ | +3.628.000 $ | +5,3 % | 1 | ||||
| ALUMIS INC. | ALMS | → 0 | Stark | 87.001.779 $ | +51.518.362 $ | +145,2 % | 1 | ||||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Sehr schwach | 83.515.271 $ | +26.110.664 $ | +45,5 % | 1 | ||||||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Schwach | 77.299.383 $ | -5.370.808 $ | -6,5 % | 1 | 82.670.191 $ | +18.411.173 $ | +28,7 % | 1 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 79.724.000 $ | +79.724.000 $ | 1 | |||||||||
| 1.253.089.776 $ | +67.260.502 $ | +11,3 % | 11 | 1.338.306.750 $ | +497.334.539 $ | +68,9 % | 9 | 658.670.993 $ | +430.618.391 $ | +345,3 % | 5 | ||||